ReviewTherapeutic advances in gastroenterology2026

Vedolizumab in inflammatory bowel disease: pharmacokinetics and the role of immunomodulator co-therapy.

Aviv Pudipeddi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.